AQR Capital Management’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $529K | Buy |
213,237
+159,115
| +294% | +$395K | ﹤0.01% | 2592 |
|
|
2025
Q1 | $83.9K | Buy |
+54,122
| New | +$83.9K | ﹤0.01% | 3040 |
|
|
2024
Q4 | – | Sell |
-15,692
| Closed | -$68.3K | – | 2875 |
|
|
2024
Q3 | $68.3K | Buy |
+15,692
| New | +$68.3K | ﹤0.01% | 2688 |
|
|
2022
Q3 | – | Sell |
-18,663
| Closed | -$46K | – | 2200 |
|
|
2022
Q2 | $46K | Buy |
18,663
+4,773
| +34% | +$11.8K | ﹤0.01% | 2138 |
|
|
2022
Q1 | $38K | Buy |
+13,890
| New | +$38K | ﹤0.01% | 2190 |
|